Pathology of IgA nephropathy.
Roberts IS.
Nat Rev Nephrol. 2014 Aug;10(8):445-54. doi: 10.1038/nrneph.2014.92. Epub 2014 May 27.
The incidence of primary glomerulonephritis worldwide: a systematic review of the literature.
McGrogan A, Franssen CF, de Vries CS.
Nephrol Dial Transplant. 2011 Feb;26(2):414-30. doi: 10.1093/ndt/gfq665. Epub 2010 Nov 10.
The classification of glomerulonephritis in systemic lupus erythematosus revisited.
Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M.
J Am Soc Nephrol. 2004 Feb;15(2):241-50. doi: 10.1097/01.asn.0000108969.21691.5d.
Postinfectious glomerulonephritis.
Kambham N.
Adv Anat Pathol. 2012 Sep;19(5):338-47. doi: 10.1097/PAP.0b013e31826663d9.
Focal segmental sclerosis or scarred focal proliferative glomerulonephritis?
Whitworth JA, Turner DR, Leibowitz S, Cameron JS.
Clin Nephrol. 1978 Jun;9(6):229-35.
IgA nephropathy.
McCoy RC, Abramowsky CR, Tisher CC.
Am J Pathol. 1974 Jul;76(1):123-44.
Diffuse proliferative glomerulonephritis in a patient with COVID-19 infection.
Flores VAG, Chicano S, Resontoc LP, Aragon EE.
BMJ Case Rep. 2023 Jan 5;16(1):e251962. doi: 10.1136/bcr-2022-251962.
Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
Strife CF, McAdams AJ, West CD.
Clin Nephrol. 1982 Jul;18(1):9-16.
Focal mesangial proliferative glomerulonephritis in the rat caused by habu snake venom. A morphologic study.
Cattell V, Bradfield JW.
Am J Pathol. 1977 Jun;87(3):511-24.
Natural history and treatment of primary proliferative glomerulonephritis: a review.
Glassock RJ.
Kidney Int Suppl. 1985 Dec;17:S136-42.
